Showing results (101-110 of 197) with videos related to

Sort By:
Pageof 20
Archives of Pathology & Laboratory Medicine|October 1, 1991
Carcinosarcoma of bladder following long-term cyclophosphamide therapyS H Sigal, J E Tomaszewski, J J Brooks, et al.
Journal of Clinical Laboratory Analysis|January 1, 1997
In situ hybridization for Helicobacter pylori in gastric mucosal biopsy specimens: quantitative evaluation of test performance in comparison with the CLOtest and thiazine stainD M Barrett, D O Faigel, D C Metz, et al.
The Journal of Urology|October 1, 1987
Urodynamic evaluation of patients after the Camey operationB Goldwasser, C C Rife, R C Benson, et al.
The Journal of Urology|February 1, 1986
Paget's disease of the urethral meatus following transitional cell carcinoma of the bladderJ E Tomaszewski, O C Korat, V A LiVolsi, et al.
Journal of the American Chemical Society|January 5, 2021
Rapid Assembly of Tetrasubstituted Furans via Pummerer-Type RearrangementFranz-Lucas Haut, Christoph Habiger, Lukas A Wein, et al.
British Journal of Cancer|April 17, 2003
Serum markers of matrix turnover as predictors for the evolution of colorectal cancer metastasis under chemotherapyB Hanke, A Wein, P Martus, et al.
The Journal of Urology|September 25, 1997
Outcome based staging for clinically localized adenocarcinoma of the prostateA V D'Amico, R Whittington, D Schultz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
Prostate-specific antigen failure despite pathologically organ-confined and margin-negative prostate cancer: the basis for an adjuvant therapy trialA V D'Amico, R Whittington, S B Malkowicz, et al.
Zeitschrift Fur Gastroenterologie|March 20, 2001
Weekly 24-h infusion of high-dose 5-fluorouracil (5-FU) with folinic acid (FA) in adjuvant therapy of colon cancerA Wein, C Riedel, W Brückl, et al.
Cancer|May 17, 2000
Prostate specific antigen outcome based on the extent of extracapsular extension and margin status in patients with seminal vesicle negative prostate carcinoma of Gleason score < or = 7A V D'Amico, R Whittington, S B Malkowicz, et al.
Pageof 20